These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3064 related articles for article (PubMed ID: 17562522)

  • 41. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.
    Hsiung GY; Alipour S; Jacova C; Grand J; Gauthier S; Black SE; Bouchard RW; Kertesz A; Loy-English I; Hogan DB; Rockwood K; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(6):483-90. PubMed ID: 18417973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subjective complaints and self-evaluation of memory test performance in Questionable dementia.
    Wong CH; Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):937-44. PubMed ID: 16927400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes.
    Xu G; Meyer JS; Thornby J; Chowdhury M; Quach M
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1027-33. PubMed ID: 12404652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restriction in complex activities of daily living in MCI: impact on outcome.
    Pérès K; Chrysostome V; Fabrigoule C; Orgogozo JM; Dartigues JF; Barberger-Gateau P
    Neurology; 2006 Aug; 67(3):461-6. PubMed ID: 16894108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between mild parkinsonian signs and mild cognitive impairment in a community.
    Louis ED; Schupf N; Manly J; Marder K; Tang MX; Mayeux R
    Neurology; 2005 Apr; 64(7):1157-61. PubMed ID: 15824340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
    J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A detection of very mild Alzheimer's disease and MCI by memory complaints and deterioration of IADL in a questionnaire for a memory clinic].
    Ueda M; Takayama Y; Koyama Y; Osada H
    No To Shinkei; 2006 Oct; 58(10):865-71. PubMed ID: 17087278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Neuropsychology; 2007 Sep; 21(5):549-58. PubMed ID: 17784803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Rev Neurol (Paris); 2010; 166(6-7):584-93. PubMed ID: 20226490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Fischer P; Jungwirth S; Zehetmayer S; Weissgram S; Hoenigschnabl S; Gelpi E; Krampla W; Tragl KH
    Neurology; 2007 Jan; 68(4):288-91. PubMed ID: 17242334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
    Anchisi D; Borroni B; Franceschi M; Kerrouche N; Kalbe E; Beuthien-Beumann B; Cappa S; Lenz O; Ludecke S; Marcone A; Mielke R; Ortelli P; Padovani A; Pelati O; Pupi A; Scarpini E; Weisenbach S; Herholz K; Salmon E; Holthoff V; Sorbi S; Fazio F; Perani D
    Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 154.